7-[2-(4-cyclopentylmethyl-piperazin-1-yl)-6-propyl-thieno[2,3-d]pyrimidin-4-yl]-3-trifluoromethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine | 1215167-73-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 7-[2-(4-cyclopentylmethyl-piperazin-1-yl)-6-propyl-thieno[2,3-d]pyrimidin-4-yl]-3-trifluoromethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
• 英文别名: 2-[4-(cyclopentylmethyl)piperazin-1-yl]-6-propyl-4-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]thieno[2,3-d]pyrimidine
• CAS: 1215167-73-9
• 化学式: C₂₅H₃₃F₃N₈S
• 分子量: 534.652
• InChiKey: CVDNINRXMQDMIF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  37
• 可旋转键数：
  6
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.68
• 拓扑面积：
  94.4
• 氢给体数：
  0
• 氢受体数：
  11

文献信息

• FUSED HETEROCYCLIC COMPOUND
  申请人：Lee Chang Seok

  公开号：US20110166121A1

  公开（公告）日：2011-07-07

  The present invention relates to a fused heterocyclic compound having the Formula 1, which is useful as a platelet aggregation inhibitor, a method for preparing the same, and a pharmaceutical composition for inhibiting platelet aggregation comprising the same.

  本发明涉及具有化学式1的融合杂环化合物，其作为血小板聚集抑制剂有用，以及制备该化合物的方法，以及包含该化合物的用于抑制血小板聚集的药物组合物。
• [EN] FUSED HETEROCYCLIC COMPOUND<br/>[FR] COMPOSÉ HÉTÉROCYCLIQUE CONDENSÉ
  申请人：LG LIFE SCIENCES LTD

  公开号：WO2010027236A2

  公开（公告）日：2010-03-11

  The present invention relates to a fused heterocyclic compound having the Formula 1, which is useful as a platelet aggregation inhibitor, a method for preparing the same, and a pharmaceutical composition for inhibiting platelet aggregation comprising the same.